Picture of Medrx logo

4586 — Medrx News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Medrx commences phase I clinical trial for spastic paralysis treatment plasters in U.S.

Oct 7 (Reuters) - Medrx Co Ltd  4586.T :   
     
     
    * Says it commenced the phase I clinical trial for spastic 
paralysis treatment plasters(MRX-4TZT) in the U.S.  
     
     
    Source text in Japanese:https://goo.gl/N7uk4m 
    Further company coverage: 4586.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724; 
Reuters Messaging: jun.cao.reuters.com@reuters.net))

Recent news on Medrx

See all news